News
Welcome to the News Page, where you will find informative articles detailing the latest research and educational efforts that are underway at Eukaryotic Pathogens Innovation Center (EPIC).
News
Welcome to the News Page, where you will find informative articles detailing the latest research and educational efforts that are underway at Eukaryotic Pathogens Innovation Center (EPIC).
News Bites Archive
Congratulations to Drs. Dan Whitehead and Alexis Stamatikos on Their Successes in Acquiring NIH Awards
Dr. Whitehead was awarded a NIH R35 MIRA grant (R35GM153221) to develop rare heterocyles to understand pathogen metabolism, while Dr. Stamatikos was awarded a NIH R01 (R01HL175166) to identify novel atheroprotective mechanisms. Both were Research Project Leaders on...
Convergent evolution in toxin detection and resistance provides evidence for conserved bacterial–fungal interactions
Stephen Dolan's latest research, published in PNAS, sheds light on the complex interactions within polymicrobial communities. The study reveals how the human pathogen Pseudomonas aeruginosa has developed a genetic network to detect and neutralize gliotoxin, a potent...
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection
A team of researchers, including Jillian Milanes, Samuel Kwain, Dan Whitehead, and Jim Morris, have published a groundbreaking study in PLOS Pathogens titled “Enolase inhibitors as therapeutic leads for Naegleria fowleri infection.” The study explores the potential of...
Follow Along
Sign up for our newsletter.